期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

以肿瘤低氧为靶点的生物还原剂的研究进展 被引量：1

Recent advances in the study of bioreductive drugs targeted tumor hypoxia
原文传递
导出
摘要 肿瘤低氧是实体瘤发展过程中必经的过程,是引起肿瘤耐药、复发、侵袭和转移的重要原因。低氧肿瘤细胞对放疗化疗有一定的耐受。肿瘤低氧已成为肿瘤药物治疗的一个重要靶点,近年来,以肿瘤低氧为靶点的生物还原剂在治疗肿瘤方面取得了很大的进展。本文对生物还原剂研究的最新进展予以综述。 Tumor hypoxia is the necessary process in the development of solid tumors, which is the key factor for drug resistance, recurrence, attack and shift of tumor. Hypoxic tumor cells have a certain extent of tolerance to radiation and chemotherapy. Tumor hypoxia is an important target for medication therapy. In the recent years, the bioreductive drugs targeted tumor hypoxia has made great process in the treatment of tumors. The latest advances of bioreductive drugs targeted hypoxia were reviewed in this paper.
作者 刘井宝 傅磊 胡永洲 姜发琴
机构地区 上海交通大学药学院药物化学教研室 浙江大学药学院药物化学教研室
出处 《药学学报》 CAS CSCD 北大核心 2009年第7期695-702,共8页 Acta Pharmaceutica Sinica
关键词 低氧 肿瘤 生物还原剂 hypoxia tumor bioreductive drug
分类号 R916 [医药卫生—药学]
  • 相关文献

参考文献21

  • 1Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators [J]. Nat Rev Drug Discov, 2008, 7: 168-181.
  • 2Danson S, Ward TH, Butler J, et al. DT-diaphorase: a target for new anticancer drugs [J]. Cancer Treat Rev, 2004, 30: 437-449.
  • 3Atkinson S J, Loadman PM, Sutton C, et al. Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation massspectrometry [J]. Rapid Commun Mass Spectr, 2007, 21:1271-1276.
  • 4FangH YangB HeQJ.The study of drug resistance mechanism and cancer therapies targeted hypoxia .中国药学杂志,2005,40:1208-1212.
  • 5Wolkenberg SE, Boger DL. Mechanisms of in situ activation for DNA-targeting antitumor agents [J]. Chem Rev, 2002, 102: 2477-2496.
  • 6Haffty BG, Wilson LD, Son YH, et al. Concurrent chemo- radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial [J]. Int J Radiat Oncol Biol Phys, 2005, 61: 119-128.
  • 7Gellis A, Kovacic H, Boufatah N, et al. Synthesis and cytotoxicity evaluation of some benzirnidazole-4,7-diones as bioreductive anticancer agents [J]. Eur J Med Chern, 2008, 43: 1858-1864.
  • 8Lynch M, Hehir S, Kavanagh R et al. Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a] benzimidazole-quinones [J]. Chem EurJ, 2007, 13: 3218-3226.
  • 9Hasinoff BB, Begleiter A. The reductive activation of the antitumor drug RH 1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells [J]. Free Radic Res, 2006, 40: 974-978.
  • 10Allos Therapeutics Inc. 2005, Annual Report. http://library corporate-ir.net/library/12/125/125475/items/193964/ALTH05AR. pdf. (Accessed May 13, 2006).

同被引文献35

  • 1Brahimi-Horn M C, Pouyssegur J. Oxygen, a source of life and stress [J]. FEBS Lett ,2007,581 ( 19 ) :3582-3591.
  • 2Poon E, Harris A L, Ashcroft M. Targeting the hypoxia-inducible factor (HIF) pathway in cancer[J]. Expert Rev Mol Med,2009 ,11 :e26.
  • 3McKeown S R, Cowen R L, Williams K J. Bioreductive drugs: from concept to clinic [ J ]. Clin Oncol (R Coll Radiol ) ,2007,19 ( 6 ) :427-442.
  • 4Ahn G O, Brown M. Targeting tumors with hypoxia-activated cytotoxins[J]. Front Biosci ,2007,12:3483-3501.
  • 5Welsh S J, Koh M Y, Powis G. The hypoxic inducible stress response as a target for cancer drug discovery [J]. Semin Oncol,2006,33 ( 4 ) :486-497.
  • 6Gillies R J, Gatenby R A. Hypoxia and adaptive land-scapes in the evolution of carcinogenesis [ J ]. Cancer Metastasis Rev, 2007,26 ( 2 ) : 311-317.
  • 7Hay M P, Pchalek K, Pruijn F B, et al. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides :the influence of hydrogen bond donors on extravaseular transport and anti- tumor activity [ J ] . J Med Chem, 2007, 50 (26): 6654- 6664.
  • 8Hay M P, Hicks K O, Pchalek K, et al. Tricyclic [ 1,2,4 ] triazine 1,4-dioxides as hypoxia selective cytotoxins [J]. J Med Chem ,2008,51 (21) :6853-6865.
  • 9Lou J,Zhou X, Weng Q, et al. XQ2, a novel TPZ derivative, induced G2/M phase arrest and apoptosis under hypoxia in non-small cell lung cancer cells [ J ]. Biosci Biotechnol Biochem,2010,74 ( 6 ) : 1181-1187.
  • 10Solano B,Junnotula V, Marfn A, et al. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluorome- thylquinoxaline 1, 4-di-N-oxide derivatives and their reduced analogues [J]. J Med Chem, 2007,50 ( 22 ) : 5485- 5492.

引证文献1

二级引证文献7

药学学报
2009年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部